CNTB
Connect Biopharma Holdings Ltd - ADR

730
Mkt Cap
$88.23M
Volume
25,769.00
52W High
$2.86
52W Low
$0.51
PE Ratio
-5.60
CNTB Fundamentals
Price
$1.55
Prev Close
$1.58
Open
$1.57
50D MA
$1.70
Beta
0.77
Avg. Volume
129,669.95
EPS (Annual)
-$0.2831
P/B
1.23
Rev/Employee
$419,887.10
Loading...
Loading...
Connect Biopharma Holdings Ltd. operates as clinical-stage biopharmaceutical company. It focuses on advancing rademikibart, an anti-interleukin-4-receptor alpha antibody, to transform acute and chronic care in asthma and chronic obstructive pulmonary disease. The company was founded by Zheng Wei and Wu Bin Pan on November 23, 2015 and is headquartered in San Diego, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
62

Frequently Asked Questions

What is Market Cap of Connect Biopharma Holdings Ltd?
What is the 52-week high for Connect Biopharma Holdings Ltd?
What is the 52-week low for Connect Biopharma Holdings Ltd?
What is Connect Biopharma Holdings Ltd stock price today?
What was Connect Biopharma Holdings Ltd stock price yesterday?
What is the PE ratio of Connect Biopharma Holdings Ltd?
What is the Price-to-Book ratio of Connect Biopharma Holdings Ltd?
What is the 50-day moving average of Connect Biopharma Holdings Ltd?
How many employess does Connect Biopharma Holdings Ltd has?

Latest CNTB News

View

Advertisement|Remove ads.

Advertisement|Remove ads.